meningitidis doses (10 6 or 10 7 CFU) independently of the genotype in spite of a nonsignificant trend for lower bacteremia in C5ar1 −/− mice ( Fig.
← all excerpts
Complement C5a Receptor 1 Exacerbates the Pathophysiology of <i>N. meningitidis</i> Sepsis and Is a Potential Target for Disease Treatment.
1
—
—